A detailed history of Laffer Tengler Investments transactions in Johnson & Johnson stock. As of the latest transaction made, Laffer Tengler Investments holds 60,652 shares of JNJ stock, worth $8.85 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
60,652
Previous 59,548 1.85%
Holding current value
$8.85 Million
Previous $8.7 Billion 12.93%
% of portfolio
1.99%
Previous 1.88%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$145.48 - $167.38 $160,609 - $184,787
1,104 Added 1.85%
60,652 $9.83 Billion
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $1.46 Million - $1.6 Million
10,126 Added 20.49%
59,548 $8.7 Billion
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $21,109 - $22,132
-136 Reduced 0.27%
49,422 $7.82 Billion
Q4 2023

Feb 08, 2024

BUY
$145.6 - $158.88 $303,867 - $331,582
2,087 Added 4.4%
49,558 $7.77 Billion
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $888,398 - $995,233
5,704 Added 13.66%
47,471 $7.39 Billion
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $650,276 - $699,821
4,213 Added 11.22%
41,767 $6.91 Billion
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $53,018 - $63,271
-351 Reduced 0.93%
37,554 $5.82 Billion
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $1.27 Million - $1.42 Million
7,899 Added 26.32%
37,905 $6.7 Billion
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $173,429 - $192,984
1,075 Added 3.72%
30,006 $4.9 Billion
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $177,776 - $196,612
-1,057 Reduced 3.52%
28,931 $5.14 Billion
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $137,581 - $156,243
-870 Reduced 2.82%
29,988 $5.31 Billion
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $238,105 - $264,186
1,527 Added 5.21%
30,858 $5.28 Billion
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $1 Million - $1.12 Million
6,215 Added 26.89%
29,331 $4.74 Billion
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $284,990 - $305,702
-1,787 Reduced 7.18%
23,116 $3.81 Billion
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $447,423 - $498,313
2,923 Added 13.3%
24,903 $4.09 Billion
Q4 2020

Jun 11, 2021

BUY
$137.11 - $157.38 $397,756 - $456,559
2,901 Added 15.21%
21,980 $3.43 Billion
Q4 2020

Feb 19, 2021

SELL
$137.11 - $157.38 $158,362 - $181,773
-1,155 Reduced 5.71%
19,079 $3 Billion
Q3 2020

Jun 11, 2021

SELL
$140.38 - $153.83 $1,544 - $1,692
-11 Reduced 0.05%
20,234 $3.01 Billion
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $157,506 - $172,597
1,122 Added 5.87%
20,245 $3.01 Billion
Q2 2020

Jun 11, 2021

BUY
$128.81 - $155.51 $158,436 - $191,277
1,230 Added 6.87%
19,123 $2.69 Billion
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $319,191 - $385,353
2,478 Added 16.08%
17,893 $2.52 Billion
Q1 2020

Apr 28, 2020

BUY
$111.14 - $153.99 $166,154 - $230,215
1,495 Added 10.74%
15,415 $2.02 Billion
Q4 2019

Feb 20, 2020

BUY
$127.5 - $146.44 $1.17 Million - $1.34 Million
9,165 Added 192.74%
13,920 $2.03 Billion
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $253 - $284
-2 Reduced 0.04%
4,755 $615 Million
Q2 2019

Aug 15, 2019

BUY
$131.15 - $144.24 $19,934 - $21,924
152 Added 3.3%
4,757 $663 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $70,654 - $78,561
-562 Reduced 10.88%
4,605 $644 Million
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $8,230 - $9,905
-67 Reduced 1.28%
5,167 $667 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $32,461 - $38,148
-267 Reduced 4.85%
5,234 $723 Million
Q2 2018

Aug 16, 2018

SELL
$119.4 - $131.76 $13,731 - $15,152
-115 Reduced 2.05%
5,501 $667 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $4,753 - $5,629
38 Added 0.68%
5,616 $720 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $66,659 - $72,958
-508 Reduced 8.35%
5,578 $779 Million
Q3 2017

Nov 16, 2017

BUY
$129.47 - $135.38 $787,954 - $823,922
6,086
6,086 $791 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.